(Q42947444)

11 November 2017

Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

11 November 2017

0 references

1 reference

non-alcoholic fatty liver

inferred from title

1 reference

5

1 reference

11 November 2017

J Oya

1

1 reference

11 November 2017

T Nakagami

2

1 reference

11 November 2017

S Sasaki

3

1 reference

11 November 2017

S Jimba

4

1 reference

11 November 2017

T Kasahara

6

1 reference

11 November 2017

T Wasada

7

1 reference

11 November 2017

H Sekiguchi

8

1 reference

11 November 2017

M Hasegawa

9

1 reference

11 November 2017

Y Endo

10

1 reference

11 November 2017

Y Iwamoto

11

1 reference

11 November 2017

4 August 2010

1 reference

European Journal of Clinical Nutrition

11 November 2017

1 reference

11 November 2017

64

1 reference

11 November 2017

10

1 reference

11 November 2017

1179-1185

1 reference

https://scigraph.springernature.com/pub.10.1038/ejcn.2010.139

11 November 2017

0 references

cites work

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

Effects of tamoxifen on hepatic fat content and the development of hepatic steatosis in patients with breast cancer: high frequency of involvement and rapid reversal after completion of tamoxifen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

Effects of N-3 fatty acids on hepatic triglyceride content in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Prospective evaluation of the diagnostic accuracy of liver ultrasonography

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

The accuracy of ultrasound in the detection of fatty infiltration of the liver

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Adipokines and cytokines in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Eicosapentaenoic acid actions on adiposity and insulin resistance in control and high-fat-fed rats: role of apoptosis, adiponectin and tumour necrosis factor-α

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Polyunsaturated fatty acid regulation of gene expression

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Dietary composition and nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Polyunsaturated fatty acids in the food chain in Japan

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Fish oil prevents sucrose-induced fatty liver but exacerbates high-safflower oil-induced fatty liver in ddy mice

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study

1 reference

https://api.crossref.org/works/10.1038%2FEJCN.2010.139

7 January 2021

Identifiers

DOI

10.1038/EJCN.2010.139

1 reference

Dimensions Publication ID

11 November 2017

0 references

1 reference